Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2024 Filed Jun 6, 2024 20:31 UTC |
Fraser Mary ClareSVP & Chief HRO
|
GrantOrdinary Shares | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027056 · wk-form4_1717705871.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,132 F1 · balance_after: As of June 4, 2024, 8,909 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,836 on June 2, 2025; 692 on October 1, 2025; 2,313 on June 1, 2026; 2,028 on June 2, 2026 and 2,040 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:38 UTC |
Majors Cary LSVP and President, Healthcare
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,200 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027088 · wk-form4_1717706296.xml · derivative · entry 3 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,200 Underlying: Ordinary Shares · 12,200 shares Expires 2034-06-04 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,050 on June 4, 2025; 3,050 on June 4, 2026; 3,050 on June 4, 2027 and 3,050 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:38 UTC |
Majors Cary LSVP and President, Healthcare
|
GrantOrdinary Shares | 2,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027088 · wk-form4_1717706296.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,054 F1 · balance_after: As of June 4, 2024, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,684 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027084 · wk-form4_1717706244.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,684 Underlying: Ordinary Shares · 15,684 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 3,921 on June 4, 2025; 3,921 on June 4, 2026; 3,921 on June 4, 2027 and 3,921 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantOrdinary Shares | 4,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027084 · wk-form4_1717706244.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,342 F1 · balance_after: As of June 4, 2024, 9,357 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:36 UTC |
Kohler Kenneth ESVP & GM, AST
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,900 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027080 · wk-form4_1717706189.xml · derivative · entry 2 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,900 Underlying: Ordinary Shares · 7,900 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 1,975 on June 4, 2025; 1,975 on June 4, 2026; 1,975 on June 4, 2027 and 1,975 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:36 UTC |
Kohler Kenneth ESVP & GM, AST
|
GrantOrdinary Shares | 1,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027080 · wk-form4_1717706189.xml · nonDerivative · entry 1 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,483 F1 · balance_after: As of June 4, 2024, 2,866 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 373 on May 31, 2025; 131 on June 2, 2025; 225 on June 2, 2025; 513 on June 4, 2025; 373 on May 31, 2026; 225 on June 2, 2026; 513 on June 4, 2026 and 513 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:35 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,264 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027076 · wk-form4_1717706138.xml · derivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,264 Underlying: Ordinary Shares · 2,264 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 566 on June 4, 2025; 566 on June 4, 2026; 566 on June 4, 2027 and 566 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:35 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantOrdinary Shares | 663 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027076 · wk-form4_1717706138.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,879 F1 · balance_after: As of June 4, 2024, 1,915 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 258 on October 1, 2024; 241 on June 2, 2025; 144 on June 2, 2025; 141 on June 2, 2025; 221 on June 4, 2025; 86 on October 1, 2025; 241 on June 1, 2026; 141 on June 2, 2026; 221 on June 4, 2026 and 221 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,720 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027073 · wk-form4_1717706086.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,720 Underlying: Ordinary Shares · 21,720 shares Expires 2034-06-04 F3 · derivative.exercise_date: This option becomes exercisable as follows: 5,430 on June 4, 2025; 5,430 on June 4, 2026; 5,430 on June 4, 2027 and 5,430 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 3,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027073 · wk-form4_1717706086.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,930 F1 · balance_after: As of June 4, 2024, 8,286 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:33 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 81,544 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027064 · wk-form4_1717705976.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,544 Underlying: Ordinary Shares · 81,544 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 20,386 on June 4, 2025; 20,386 on June 4, 2026; 20,386 on June 4, 2027 and 20,386 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:33 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantOrdinary Shares | 12,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027064 · wk-form4_1717705976.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,316 F1 · balance_after: As of June 4, 2024, 28,295 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:32 UTC |
Burton Karen LVP & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,144 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027060 · wk-form4_1717705926.xml · derivative · entry 2 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,144 Underlying: Ordinary Shares · 3,144 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 786 on June 4, 2025; 786 on June 4, 2026; 786 on June 4, 2027 and 786 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:32 UTC |
Burton Karen LVP & CAO
|
GrantOrdinary Shares | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027060 · wk-form4_1717705926.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,388 F1 · balance_after: As of June 4, 2024, 2,416 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 86 on October 1, 2024; 340 on June 2, 2025; 225 on June 2, 2025; 196 on June 2, 2025; 306 on June 4, 2025; 86 on October 1, 2025; 340 on June 1, 2026; 225 on June 2, 2026; 306 on June 4, 2026 and 306 on June 4, 2027. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 126 | $228.37 | $28,774.62 |
DisclosureSEC source: 0001628280-24-026868 · wk-form4_1717619636.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,045 F3 · shares: 126 shares were withheld from the 352 restricted shares that vested on June 3, 2024. These 126 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 352 ordinary shares were awarded to Ms. Madsen on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 2,857 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 129 | $228.37 | $29,459.73 |
DisclosureSEC source: 0001628280-24-026868 · wk-form4_1717619636.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,171 F2 · shares: 129 shares were withheld from the 360 restricted shares that vested on June 3, 2024. These 129 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 360 ordinary shares were awarded to Ms. Madsen on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 44 | $228.37 | $10,048.28 |
DisclosureSEC source: 0001628280-24-026868 · wk-form4_1717619636.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,300 F1 · shares: 44 shares were withheld from the 123 restricted shares that vested on June 3, 2024. These 44 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:39 UTC |
Fraser Mary ClareSVP & Chief HRO
|
Tax withholdingOrdinary Shares | 236 | $228.37 | $53,895.32 |
DisclosureSEC source: 0001628280-24-026880 · wk-form4_1717619982.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,092 F1 · shares: 236 shares were withheld from the 791 restricted shares that vested on June 3, 2024. These 236 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 791 ordinary shares were awarded to Ms. Fraser on August 4, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. F2 · balance_after: As of June 3, 2024, 6,869 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,836 on June 2, 2025; 692 on October 1, 2025; 2,313 on June 1, 2026 and 2,028 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:38 UTC |
Majors Cary LSVP and President, Healthcare
|
Tax withholdingOrdinary Shares | 694 | $228.37 | $158,488.78 |
DisclosureSEC source: 0001628280-24-026878 · wk-form4_1717619901.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,675 F1 · shares: 694 shares were withheld from the 2,376 restricted shares that vested on June 3, 2024. These 694 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,376 ordinary shares were awarded to Mr. Majors on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. F2 · balance_after: As of June 3, 2024, 7,493 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026 and 2,140 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 253 | $228.37 | $57,777.61 |
DisclosureSEC source: 0001628280-24-026875 · wk-form4_1717619814.xml · nonDerivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,214 F3 · shares: 253 shares were withheld from the 846 restricted shares that vested on June 3, 2024. These 253 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 846 ordinary shares were awarded to Mr. Zangerle on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024 5,229 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 245 | $228.37 | $55,950.65 |
DisclosureSEC source: 0001628280-24-026875 · wk-form4_1717619814.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,467 F2 · shares: 245 shares were withheld from the 819 restricted shares that vested on June 3, 2024. These 245 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 819 ordinary shares were awarded to Mr. Zangerle on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 225 | $228.37 | $51,383.25 |
DisclosureSEC source: 0001628280-24-026875 · wk-form4_1717619814.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,712 F1 · shares: 225 shares were withheld from the 752 restricted shares that vested on June 3, 2024. These 225 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 752 ordinary shares were awarded to Mr. Zangerle on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:35 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 506 | $228.37 | $115,555.22 |
DisclosureSEC source: 0001628280-24-026873 · wk-form4_1717619741.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,507 F3 · shares: 506 shares were withheld from the 1,128 restricted shares that vested on June 3, 2024. These 506 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,128 ordinary shares were awarded to Mr. Tokich on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 4,863 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:35 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 771 | $228.37 | $176,073.27 |
DisclosureSEC source: 0001628280-24-026873 · wk-form4_1717619741.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,013 F2 · shares: 771 shares were withheld from the 1,719 restricted shares that vested on June 3, 2024. These 771 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,719 ordinary shares were awarded to Mr. Tokich on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:35 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 1,100 | $228.37 | $251,207.00 |
DisclosureSEC source: 0001628280-24-026873 · wk-form4_1717619741.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,784 F1 · shares: 1,100 shares were withheld from the 2,452 restricted shares that vested on June 3, 2024. These 1,100 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,452 ordinary shares were awarded to Mr. Tokich on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 85 | $228.37 | $19,411.45 |
DisclosureSEC source: 0001628280-24-026871 · wk-form4_1717619685.xml · nonDerivative · entry 3 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,216 F3 · shares: 85 shares were withheld from the 282 restricted shares that vested on June 3, 2024. These 85 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 282 ordinary shares were awarded to Mr. Tamaro on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 1,252 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 258 on October 1, 2024; 241 on June 2, 2025; 144 on June 2, 2025; 141 on June 2, 2025; 86 on October 1, 2025; 241 on June 1, 2026 and 141 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 129 | $228.37 | $29,459.73 |
DisclosureSEC source: 0001628280-24-026871 · wk-form4_1717619685.xml · nonDerivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,301 F2 · shares: 129 shares were withheld from the 432 restricted shares that vested on June 3, 2024. These 129 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 432 ordinary shares were awarded to Mr. Tamaro on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:34 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 175 | $228.37 | $39,964.75 |
DisclosureSEC source: 0001628280-24-026871 · wk-form4_1717619685.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,430 F1 · shares: 175 shares were withheld from the 584 restricted shares that vested on June 3, 2024. These 175 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 584 ordinary shares were awarded to Mr. Tamaro on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:32 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 68 | $228.37 | $15,529.16 |
DisclosureSEC source: 0001628280-24-026865 · wk-form4_1717619528.xml · nonDerivative · entry 3 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,944 F3 · shares: 68 shares were withheld from the 225 restricted shares that vested on June 3, 2024. These 68 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 225 ordinary shares were awarded to Mr. Kohler on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 1,327 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 373 on May 31, 2025; 131 on June 2, 2025; 225 on June 2, 2025; 373 on May 31, 2026; 225 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:32 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 40 | $228.37 | $9,134.80 |
DisclosureSEC source: 0001628280-24-026865 · wk-form4_1717619528.xml · nonDerivative · entry 2 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,012 F2 · shares: 40 shares were withheld from the 131 restricted shares that vested on June 3, 2024. These 40 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 131 ordinary shares were awarded to Mr. Kohler on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:32 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 46 | $228.37 | $10,505.02 |
DisclosureSEC source: 0001628280-24-026865 · wk-form4_1717619528.xml · nonDerivative · entry 1 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,052 F1 · shares: 46 shares were withheld from the 154 restricted shares that vested on June 3, 2024. These 46 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 154 ordinary shares were awarded to Mr. Kohler on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:31 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 680 | $228.37 | $155,291.60 |
DisclosureSEC source: 0001628280-24-026863 · wk-form4_1717619474.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,530 F2 · shares: 680 shares were withheld from the 1,514 restricted shares that vested on June 3, 2024. These 680 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,514 ordinary shares were awarded to Mr. Carestio on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:31 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 480 | $228.37 | $109,617.60 |
DisclosureSEC source: 0001628280-24-026863 · wk-form4_1717619474.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,210 F1 · shares: 480 shares were withheld from the 1,108 restricted shares that vested on June 3, 2024. These 480 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,108 ordinary shares were awarded to Mr. Carestio on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:30 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 68 | $228.37 | $15,529.16 |
DisclosureSEC source: 0001628280-24-026860 · wk-form4_1717619416.xml · nonDerivative · entry 3 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,470 F3 · shares: 68 shares were withheld from the 225 restricted shares that vested on June 3, 2024. These 68 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 225 ordinary shares were awarded to Ms. Burton on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 1,498 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 86 on October 1, 2024; 340 on June 2, 2025; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025; 340 on June 1, 2026 and 225 on June 2, 2026. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:30 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 59 | $228.37 | $13,473.83 |
DisclosureSEC source: 0001628280-24-026860 · wk-form4_1717619416.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,538 F2 · shares: 59 shares were withheld from the 196 restricted shares that vested on June 3, 2024. These 59 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 196 ordinary shares were awarded to Ms. Burton on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:30 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 60 | $228.37 | $13,702.20 |
DisclosureSEC source: 0001628280-24-026860 · wk-form4_1717619416.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,597 F1 · shares: 60 shares were withheld from the 198 restricted shares that vested on June 3, 2024. These 60 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 198 ordinary shares were awarded to Ms. Burton on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:31 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 124 | $222.88 | $27,637.12 |
DisclosureSEC source: 0001628280-24-026578 · wk-form4_1717533094.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,347 F1 · shares: 124 shares were withheld from the 426 restricted shares that vested on May 31, 2024. These 124 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 426 ordinary shares were awarded to Mr. Xilas on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 2,486 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:35 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 207 | $222.88 | $46,136.16 |
DisclosureSEC source: 0001628280-24-026590 · wk-form4_1717533310.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,344 F1 · shares: 207 shares were withheld from the 578 restricted shares that vested on May 31, 2024. These 207 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 578 ordinary shares were awarded to Ms. Madsen on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 3,692 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:37 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 72 | $222.88 | $16,047.36 |
DisclosureSEC source: 0001628280-24-026595 · wk-form4_1717533418.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,605 F1 · shares: 72 shares were withheld from the 241 restricted shares that vested on May 31, 2024. These 72 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 241 ordinary shares were awarded to Mr. Tamaro on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 2,550 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 584 on June 3, 2024; 282 on June 3, 2024; 432 on June 3, 2024; 258 on October 1, 2024; 241 on June 2, 2025; 144 on June 2, 2025; 141 on June 2, 2025; 86 on October 1, 2025; 241 on June 1, 2026 and 141 on June 2, 2026. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:41 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 112 | $222.88 | $24,962.56 |
DisclosureSEC source: 0001628280-24-026602 · wk-form4_1717533656.xml · nonDerivative · entry 1 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,098 F1 · shares: 112 shares were withheld from the 373 restricted shares that vested on May 31, 2024. These 112 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 373 ordinary shares were awarded to Mr. Kohler on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 1,837 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 154 on June 1, 2024; 131 on June 2, 2024; 225 on June 2, 2024; 373 on May 31, 2025; 131 on June 2, 2025; 225 on June 2, 2025; 373 on May 31, 2026; 225 on June 2, 2026. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:40 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 346 | $222.88 | $77,116.48 |
DisclosureSEC source: 0001628280-24-026600 · wk-form4_1717533597.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,937 F1 · shares: 346 shares were withheld from the 1,157 restricted shares that vested on May 31, 2024. These 346 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,157 ordinary shares were awarded to Mr. Zangerle on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 7,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:38 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 580 | $222.88 | $129,270.40 |
DisclosureSEC source: 0001628280-24-026597 · wk-form4_1717533504.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,884 F1 · shares: 580 shares were withheld from the 1,293 restricted shares that vested on May 31, 2024. These 580 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,293 ordinary shares were awarded to Mr. Tokich on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 10,162 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:34 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 102 | $222.88 | $22,733.76 |
DisclosureSEC source: 0001628280-24-026588 · wk-form4_1717533253.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,657 F1 · shares: 102 shares were withheld from the 340 restricted shares that vested on May 31, 2024. These 102 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 340 ordinary shares were awarded to Ms. Burton on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 2,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 340 on June 2, 2025; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025; 340 on June 1, 2026 and 225 on June 2, 2026. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:32 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 1,286 | $222.88 | $286,623.68 |
DisclosureSEC source: 0001628280-24-026583 · wk-form4_1717533170.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,690 F1 · shares: 1,286 shares were withheld from the 4,308 restricted shares that vested on May 31, 2024. These 1,286 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,308 ordinary shares were awarded to Mr. Carestio on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 20,437 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC |
Breeden Richard CDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 4,584 | $0.00 Strike: $51.53 | $0.00 |
DisclosureSEC source: 0001628280-24-024972 · wk-form4_1716496445.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 4,584 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,584 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC |
Breeden Richard CDirector
|
Exercise / conversionOrdinary Shares | 4,584 | $51.53 | $236,213.52 |
DisclosureSEC source: 0001628280-24-024972 · wk-form4_1716496445.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,154 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-024375 · wk-form4_1716237087.xml · derivative · entry 3 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,872 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 2,872 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 2,872 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
SaleOrdinary Shares | 1,154 | $231.64 | $267,312.56 |
DisclosureSEC source: 0001628280-24-024375 · wk-form4_1716237087.xml · nonDerivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,677 F1 · balance_after: As of May 16, 2024, 2,791 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 241 on May 31, 2024; 584 on June 3, 2024; 282 on June 3, 2024; 432 on June 3, 2024; 258 on October 1, 2024; 241 on June 2, 2025; 144 on June 2, 2025; 141 on June 2, 2025; 86 on October 1, 2025; 241 on June 1, 2026 and 141 on June 2, 2026. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionOrdinary Shares | 1,154 | $114.22 | $131,809.88 |
DisclosureSEC source: 0001628280-24-024375 · wk-form4_1716237087.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.